Skip to Main Content
Biological & Biomedical Sciences
Yale Home

INFORMATION FOR

    Breast

    An observational study of circulating tumor DNA in triple negative breast cancers with residual disease after standard neoadjuvant treatment.

    What is the purpose of this trial?

    Estimate the ctDNA positivity rate in triple negative breast cancer (TNBC) patients with residual disease after completion of neoadjuvant chemotherapy and surgery.

    Find out more about who can participate in this trial

    Contact Information

    For more information about this study, including how to volunteer, contact Mariya Rozenblit

    Help Us Discover!

    You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

    Create a volunteer profile

    Principal Investigator

    Sub-Investigators

    • Last Updated
      09/30/2024
    • Study HIC
      #2000033096

    Contact Information

    For more information about this study, including how to volunteer, contact Mariya Rozenblit